Assessment of radioiodine therapy efficacy for treatment of differentiated thyroid cancer patients with pulmonary metastasis undetected by chest computed tomography.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 26893676)

Published in Oncol Lett on December 15, 2015

Authors

Bin Long1, Mengdi Yang1, Zhiwen Yang1, Heqing Yi1, Linfa Li1

Author Affiliations

1: Department of Nuclear Medicine, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.

Articles cited by this

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2009) 35.34

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]. Cancer (1998) 8.03

The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation. Eur J Endocrinol (2008) 1.74

Differentiated thyroid cancer presenting initially with distant metastasis. Am J Surg (1997) 1.71

Delayed initial radioactive iodine therapy resulted in poor survival in patients with metastatic differentiated thyroid carcinoma: a retrospective statistical analysis of 198 cases. J Nucl Med (2011) 1.45

Low-risk differentiated thyroid cancer: the need for selective treatment. Ann Surg Oncol (1997) 1.44

Current status and future perspectives in differentiated thyroid cancer. Endocrinol Metab (Seoul) (2014) 1.29

Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med (1993) 1.26

Papillary thyroid carcinomas with lung metastases. Thyroid (2004) 1.18

Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging (2004) 1.05

Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis. Ann Surg Oncol (2012) 1.02

Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results? J Nucl Med (2005) 0.97

Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment. Eur J Nucl Med Mol Imaging (2005) 0.82

Is chest x-ray or high-resolution computed tomography scan of the chest sufficient investigation to detect pulmonary metastasis in pediatric differentiated thyroid cancer? Thyroid (2004) 0.81

Long-term survival and low effective cumulative radioiodine doses to achieve remission in patients with 131Iodine-avid lung metastasis from differentiated thyroid cancer. Clin Nucl Med (2014) 0.81

Diagnostic whole-body scanning before radioiodine therapy for pulmonary metastases of differentiated thyroid cancer: predictive value and recommendations. Clin Nucl Med (2008) 0.79

Geometric models in dosimetry of thyroid remnant mass. Nuklearmedizin (2008) 0.79

Articles by these authors

Autophagy: A potential target for thyroid cancer therapy (Review). Mol Clin Oncol (2014) 0.79